Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospectsBrigitte Bauvois(Inserm), Daniel Dauzonne(Centre National de la Recherche Scientifique)Medicinal Research ReviewsJanuary 1, 200510.1002/med.20044Cited by 265SaveCiteExport RISWatch citationsRelated PapersACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia|Leukemia|2023|30Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells|Oncotarget|2014|15